| 注册
首页|期刊导航|现代医药卫生|基于胆汁酸-法尼醇X受体轴探讨中医药对非酒精性脂肪性肝病脂代谢的研究进展

基于胆汁酸-法尼醇X受体轴探讨中医药对非酒精性脂肪性肝病脂代谢的研究进展

张浩岩 梁得稳 高望

现代医药卫生2025,Vol.41Issue(9):2054-2057,2062,5.
现代医药卫生2025,Vol.41Issue(9):2054-2057,2062,5.DOI:10.3969/j.issn.1009-5519.2025.09.008

基于胆汁酸-法尼醇X受体轴探讨中医药对非酒精性脂肪性肝病脂代谢的研究进展

Research progress of traditional Chinese medicine on lipid metabolism of non-alcoholic fatty liver disease based on bile acid-farnesol X receptor axis

张浩岩 1梁得稳 2高望2

作者信息

  • 1. 天津中医药大学,天津 301617
  • 2. 天津中医药大学第二附属医院消化科,天津 300250
  • 折叠

摘要

Abstract

Non-alcoholic fatty liver disease(NAFLD)is a clinicopathologic syndrome,which is usually accompanied by metabolic disorders such as obesity,hyperlipidemia,and hyperglycemia.Farnesoid X Receptor(FXR)can regulate human lipid metabolism,and bile acid is its most important endogenous receptor.In recent years,the bile acid-FXR axis had become a hot research mechanism for the treatment of NAFLD.Traditional Chinese medicine is safe and effective in clinical application because of its multi-target and multi-pathway char-acteristics.At present,the research on the treatment of NAFLD from the perspective of bile acid-FXR receptor axis is also increasing.This article introduced the mechanism of bile acid-FXR receptor axis and its effect on lipid metabolism and the research progress of traditional Chinese medicine on lipid metabolism of NAFLD.

关键词

非酒精性脂肪性肝病/法尼醇X受体/胆汁酸/脂代谢/中医药/综述

Key words

Non-alcoholic fatty liver disease/Farnesol X receptor/Bile acids/Lipid metabolism/Tra-ditional Chinese medicine/Review

分类

医药卫生

引用本文复制引用

张浩岩,梁得稳,高望..基于胆汁酸-法尼醇X受体轴探讨中医药对非酒精性脂肪性肝病脂代谢的研究进展[J].现代医药卫生,2025,41(9):2054-2057,2062,5.

基金项目

天津市卫生健康委员会中医中西医结合项目(2023028) (2023028)

天津市教委科研计划项目(2023KJ171) (2023KJ171)

天津中医药大学第二附属医院"育才计划"科技项目(YC-ZD202304). (YC-ZD202304)

现代医药卫生

1009-5519

访问量0
|
下载量0
段落导航相关论文